Press release
Pharmacogenomics Market Accretes Dramatically With A Whooping CAGR ~5.8 %, Global Share, Size by Year 2023; Confirms MRFR
The pharmacogenomics market is growing at an incremental pace of development on the global stage due to the large number of advantages associated to personalized therapy. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, recently forecasted in its report on Global Pharmacogenomics Market Research Report- Forecast to 2023 that the market will demonstrate an exceptional CAGR ~5.8 % while achieving million dollar growth readily in the forecast period.
The key players profiled in pharmacogenomics market report includes Myriad Genetics, Inc. (U.S.), 23andMe, Inc. (U.S.), Pathway Genomics (U.S.), GeneTech (U.S.), GeneDx. (U.S.), Future Science Group (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Assurex Health, Inc. (U.S.), OneOme (U.S.) and others.
Avail Sample Research Report at https://www.marketresearchfuture.com/sample_request/1177
Latest Industry Updates
Nov 2017: Myriad Genetics, Inc., announced positive results from a double-blind, multi-center, randomized controlled trial assessing the impact of the GeneSight Psychotropic test (GeneSight) on psychiatric treatment response in 1,200 patients with major depressive disorder. GeneSight is one of the leading pharmacogenomics test to help guide medication selection for mental health disorders.
June 2016: OneOme announced about key business milestones in advance of launching its RightMed test. RightMed test is a cost-effective, comprehensive, personalized pharmacogenomics product which analyses 22 genes which provided at the point of care. The OneOme platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care. OneOme’s RightMed test is currently in use by Mayo Clinic Center for individualized medicine. The test helps providers easily make personalized treatment decisions across more than 300 medications for more than 20 medical indications.
Pharmacogenomics plays an important role in drug discovery and development. Pharmacogenomics refers to the effects of genetic polymorphism and genomic variants on drug response, its information can help in selection of the optimal drug, dose, treatment process, and avoid adverse drug reactions. As adverse drug reactions have been reported as one of the leading causes of death among hospitalized patients. Adverse drug reactions are also referred as the factor behind loss of confidence in the healthcare system and the diminishing satisfaction of both patients and health professionals.
Pharmacogenomics approach aids pharmaceutical companies to design drugs that satisfies the requirements of particular genetic sub-groups of the general population. The main interest of pharmacogenomics is to identify patients for whom drug efficacy can be predicted, and to reduce risk of adverse drugs effects. The main and important pharmacogenomics approaches is to prescribe drugs on the basis of their patients’ genetic profiles which is termed as ‘personalized medicine.
Brows Full Detailed Report at https://www.marketresearchfuture.com/reports/pharmacogenomics-market-1177
Global Pharmacogenomics Market - Regional Analysis
The global pharmacogenomics market is segmented into Americas, Europe, Asia Pacific and the Middle East & Africa. Global pharmacogenomics market is highly dominated by North America and Europe due to majority of pharmaceutical companies engaged in research & development activities, increasing awareness about side effects of a drug among the people, production of next generation PCR technology and microarray system which drive the growth of this market.
APAC is fastest growing region due to the presence of a huge patient population, continuously developing economies like India and China and presence of huge opportunities drives the market growth. For instance, According to the Indian Brand Equity Foundation in 2016, the Indian biotech industry is estimated to reach USD 100 billion by 2025 from USD 7.0 billion in 2015.
Intended Audience
Pharmaceutical companies
Biotechnological institutes
Government and Private Laboratories
Research and Development (R&D) Companies
Medical Research Laboratories
Market Research and Consulting Service Providers
Inquire for Discount at https://www.marketresearchfuture.com/check-discount/1177
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Accretes Dramatically With A Whooping CAGR ~5.8 %, Global Share, Size by Year 2023; Confirms MRFR here
News-ID: 1436565 • Views: …
More Releases from Market Research Future
Cerebral Palsy Industry Projected to Reach USD 4.036 billion by 2035 with Steady …
The global healthcare sector continues to place increasing emphasis on neurological disorders that require long-term management and multidisciplinary care. Among these, cerebral palsy remains one of the most common childhood motor disabilities, affecting movement, posture, and muscle coordination. As awareness grows and treatment options continue to advance, the cerebral palsy industry is witnessing steady expansion driven by improved diagnosis, therapeutic innovation, and rising investments in rehabilitation services.
According to Market Research…
Reclaimed Lumber Market revenue expected to rise from USD 53.47 Billion in 2024 …
Based on the market research report from Market Research Future, here is a detailed overview of the global reclaimed lumber market. This sector is thriving at the intersection of environmental sustainability and distinctive design.
What is Reclaimed Lumber?
Reclaimed lumber is wood sourced from old structures like barns, factories, warehouses, and wine barrels, which is then processed and remilled for new use. It offers a unique combination of environmental benefits-reducing deforestation and…
Cardiovascular Information Systems Industry Expected to Reach USD 1,330.86 milli …
The global healthcare sector is undergoing a rapid digital transformation, particularly in specialized areas such as cardiovascular care where data accuracy, workflow efficiency, and real-time monitoring are critical. Cardiovascular Information Systems (CVIS) have emerged as essential platforms that integrate imaging, patient records, diagnostic data, and clinical workflows to support comprehensive cardiac care management.
According to Market Research Future (MRFR), the Cardiovascular Information System Market was valued at USD 640.0 million in…
Low E-Glass Industry forecast highlights robust 6.5% CAGR growth through 2035
Low-emissivity (Low-E) glass has a microscopically thin, transparent coating that reflects infrared energy (heat) while allowing visible light to pass through. This principle helps keep buildings warm in the winter by reflecting interior heat back inside, and cool in the summer by blocking exterior heat, all while reducing harmful UV rays.
The Global Low-E Glass Market: An Overview
The global Low-E glass market is on a strong growth trajectory, driven by the…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
